Lindeman Asia Investment Co. Ltd (277070) - Total Liabilities
Based on the latest financial reports, Lindeman Asia Investment Co. Ltd (277070) has total liabilities worth ₩7.36 Billion KRW (≈ $4.99 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 277070 cash flow metrics to assess how effectively this company generates cash.
Lindeman Asia Investment Co. Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how Lindeman Asia Investment Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Lindeman Asia Investment Co. Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Lindeman Asia Investment Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Lindeman Asia Investment Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
American West Metals Ltd
AU:AW1
|
Australia | AU$13.81 Million |
|
Eduspec Holdings Bhd
KLSE:0107
|
Malaysia | RM32.07 Million |
|
Acanthe Développement
PA:ACAN
|
France | €21.07 Million |
|
Transworld Shipping Lines Limited
NSE:TRANSWORLD
|
India | Rs3.66 Billion |
|
Logistea A
ST:LOGI-A
|
Sweden | Skr9.57 Billion |
|
Yotta Acquisition Corporation Common Stock
NASDAQ:YOTA
|
USA | $8.47 Million |
|
China Television Co
TW:9928
|
Taiwan | NT$3.11 Billion |
|
Rave Restaurant Group Inc
NASDAQ:RAVE
|
USA | $2.01 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Lindeman Asia Investment Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Lindeman Asia Investment Co. Ltd (277070) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 41.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lindeman Asia Investment Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lindeman Asia Investment Co. Ltd (2015–2024)
The table below shows the annual total liabilities of Lindeman Asia Investment Co. Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩10.77 Billion ≈ $7.30 Million |
+3.48% |
| 2023-12-31 | ₩10.41 Billion ≈ $7.05 Million |
-9.75% |
| 2022-12-31 | ₩11.53 Billion ≈ $7.82 Million |
+4.21% |
| 2021-12-31 | ₩11.07 Billion ≈ $7.50 Million |
-33.79% |
| 2020-12-31 | ₩16.71 Billion ≈ $11.33 Million |
+112.30% |
| 2019-12-31 | ₩7.87 Billion ≈ $5.33 Million |
+125.47% |
| 2018-12-31 | ₩3.49 Billion ≈ $2.37 Million |
+117.16% |
| 2017-12-31 | ₩1.61 Billion ≈ $1.09 Million |
-9.14% |
| 2016-12-31 | ₩1.77 Billion ≈ $1.20 Million |
+12.21% |
| 2015-12-31 | ₩1.58 Billion ≈ $1.07 Million |
-- |
About Lindeman Asia Investment Co. Ltd
Lindeman Asia Investment Co., Ltd. is a venture capital and private equity firm specializing in small and medium sized venture companies, equity, mezzanine, 1st, 2nd and 3rd round investments. The firm primarily makes investments in pre-IPO, middle market companies and emerging growth, operating in the bio and healthcare, chemistry and material, game and contents, ICT manufacturing, ICT service, … Read more